Résultats de la recherche - 118 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
cancer screening data and the national cancer registry, demonstrates excellent protection against invasive cervical cancer among girls immunized at the age of 12 to 13 years with the bivalent human ...
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
to international criteria is prerequisite for their implementation in cervical cancer screening. OncoPredict HPV Quantitative Typing (QT) assay (Hiantis Srl, Milan, Italy) is a novel full-genotyping ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
support a strategy to eliminate cervical cancer as a public health problem, the World Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical pre-cancerous lesions in 2021. ...
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
triage Uterine Cervical Neoplasms Abstract: In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as a public health problem. To support the strategy, the WHO ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Organised Cervical Cancer Screening Programme (OCCSP) was started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test every 3 years in OCCSP. Despite implementation of the OCCSP, ...
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
Almonte, Maribel Source: Br J Cancer (2023) Keywords: Cervical cardiogenesis Cervical lesions HPV Abstract: BACKGROUND: Cervical carcinogenesis is mediated by the HPV- E6 and E7 oncoproteins, considered as ...
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
in comprehensive HPV prevention strategies to reduce HPV-related morbidity and mortality in men and ultimately achieve elimination of cervical cancer and other HPV-related diseases. FUNDING: Instituto ...
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
of the National Reference Center for HPV in Belgium. Specimens were collected in the context of cervical cancer screening and tested in two different laboratories. The international reproducibility ...
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Cervical Cancer Elimination Strategy recommend human papillomavirus (HPV) testing as the primary screening test. However, HPV testing is not widely available in the public healthcare system in Kenya. We ...